Non-invasive, targeted, and non-viral ultrasound-mediated brain-derived neurotrophic factor plasmid delivery for treatment of autism in a rat model.

Front Neurosci · 2022 · PMC9475200 · PMID 36117626

Europe PMC DOI

hedged sentence

0.1227

closest p · 2.5× alpha

0.1227

boldest claim

The sentences

an increasing trendp = 0.1227not close (p > 0.1)

After treatment, compared to the VPA group, the number of times of standing upright of the BDNFp group was significantly increased, and the FUS + BDNFp-CMBs group showed an increasing trend ( p = 0.1227).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.